Alpha 2.0
Login Register
» Authors » Ole Hoie

Ole Hoie

Explore the profile of Ole Hoie including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 1211
Followers 0
Related Specialties
Gastroenterology
Pharmacology
General Medicine
Top 10 Co-Authors
Bjorn Moum
Gert Huppertz-Hauss
Geir Hoff
Tomm Bernklev
Magne Henriksen
Michael Bretthauer
Marte Lie Hoivik
Oistein Hovde
Morten Vatn
Jorgen Jahnsen
Published In
Scand J Gastroenterol
Inflamm Bowel Dis
J Crohns Colitis
Endosc Int Open
Gastroenterology
Affiliations
Soon will be listed here.
Recent Articles
1.
Low Surgery Rates in Early Crohn's Disease: Results from a Prospective Population-Based Inception Cohort-The Inflammatory Bowel Disease in South-Eastern Norway III Study
Lund C, Strande V, Hagen M, Bengtson M, Boyar R, Detlie T, et al.
Inflamm Bowel Dis . 2024 Dec; PMID: 39699202
Background And Aims: The emergence of biologic therapy has coincided with a decline in surgery rates for Crohn's disease (CD). This study aims to describe the disease course, including intra-abdominal...
2.
Clinical course of ulcerative colitis: Frequent use of biologics and low colectomy rate first year after diagnosis-results from the IBSEN III inception cohort
Strande V, Lund C, Hagen M, Bengtson M, Cetinkaya R, Detlie T, et al.
Aliment Pharmacol Ther . 2024 Jun; 60(3):357-368. PMID: 38837289
Background: The introduction of biologic therapies and the 'treat-to-target' treatment strategy may have changed the disease course of ulcerative colitis (UC). Aims: To describe the early disease course and disease...
3.
Inflammatory bowel disease in South-Eastern Norway III (IBSEN III): a new population-based inception cohort study from South-Eastern Norway
Kristensen V, Opheim R, Perminow G, Huppertz-Hauss G, Detlie T, Lund C, et al.
Scand J Gastroenterol . 2021 Jun; 56(8):899-905. PMID: 34154494
Background And Aim: Modern treatment strategies for inflammatory bowel disease (IBD) are postulated to change the natural disease course. Inception cohort studies are the gold standard for investigating such changes....
4.
Outcome of Ulcerative Colitis 20 Years after Diagnosis in a Prospective Population-based Inception Cohort from South-Eastern Norway, the IBSEN Study
Monstad I, Solberg I, Cvancarova M, Hovde O, Henriksen M, Huppertz-Hauss G, et al.
J Crohns Colitis . 2020 Dec; 15(6):969-979. PMID: 33367569
Background And Aims: The long-term course of ulcerative colitis [UC] is difficult to predict. Mortality, colectomy, cancer, and hospitalisation represent hard outcomes of disease. Moreover, knowledge on the risk of...
5.
Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study
Klepp P, Brackmann S, Cvancarova M, Hoivik M, Hovde O, Henriksen M, et al.
BMJ Open Gastroenterol . 2020 Apr; 7(1):e000361. PMID: 32337058
Objective: The association between ulcerative colitis (UC) and colorectal cancer (CRC) is widely accepted, although attenuated risk has been reported in recent years. Colonoscopic surveillance is recommended with intervals based...
6.
No major reduction in bone mineral density after long-term treatment of patients with Celiac Disease
Haere P, Hoie O, Lundin K, Haugeberg G
Eur J Intern Med . 2019 Aug; 68:23-29. PMID: 31401019
Background: At time of diagnosis, patients with celiac disease (CD) have been shown to have lower bone mineral density (BMD) than healthy controls. It is unclear whether adult patients with...
7.
Registration bias in a clinical quality register
Hoff G, de Lange T, Bretthauer M, Dahler S, Halvorsen F, Huppertz-Hauss G, et al.
Endosc Int Open . 2019 Jan; 7(1):E90-E98. PMID: 30652120
 The quality of medical quality registers is poorly defined and lack of trust in data due to low completeness may be a major barrier against their use in quality improvement...
8.
Ankylosing Spondylitis and Axial Spondyloarthritis in Patients With Long-term Inflammatory Bowel Disease: Results From 20 Years of Follow-up in the IBSEN Study
Ossum A, Palm O, Lunder A, Cvancarova M, Banitalebi H, Negard A, et al.
J Crohns Colitis . 2017 Sep; 12(1):96-104. PMID: 28961700
Background: Patients with inflammatory bowel disease [IBD] often suffer from rheumatic manifestations, including inflammatory back disorders. The prevalence of these disorders late in the course of IBD is poorly investigated....
9.
Cecum intubation rate as quality indicator in clinical versus screening colonoscopy
Hoff G, Holme O, Bretthauer M, Sandvei P, Darre-Naess O, Stallemo A, et al.
Endosc Int Open . 2017 Jun; 5(6):E489-E495. PMID: 28573182
Background And Study Aims: Some guidelines recommend a minimum standard of 90 % cecal intubation rate (CIR) in routine clinics and 95 % in screening colonoscopy, while others have not...
10.
Patient-reported adverse events after colonoscopy in Norway
Hoff G, de Lange T, Bretthauer M, Buset M, Dahler S, Halvorsen F, et al.
Endoscopy . 2017 Apr; 49(8):745-753. PMID: 28445903
 Patient-reported outcome measures are increasingly important in healthcare. European guidelines have recommended inclusion of patient feedback to capture adverse events due to colonoscopy, but this is rarely implemented.  The Norwegian...